NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$43.83 +1.00 (+2.33 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$43.83
Today's Range$42.82 - $44.22
52-Week Range$42.29 - $91.16
Volume185,326 shs
Average Volume383,624 shs
Market Capitalization$963.73 million
P/E Ratio128.91
Dividend YieldN/A
Beta1.51
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software applications also comprise RxCompanion, a medication therapy management software platform for the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting for PACE organizations and small health plans. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2018, it served 224 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, and healthcare organizations for managing the medication-related needs of their patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$204.27 million
Cash Flow$1.1620 per share
Book Value$8.33 per share

Profitability

Net Income$-47,270,000.00

Miscellaneous

Employees952
Market Cap$963.73 million
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) issued its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $60.96 million for the quarter, compared to analysts' expectations of $59.24 million. Tabula Rasa HealthCare had a negative net margin of 18.15% and a positive return on equity of 4.22%. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its FY 2019 earnings guidance on Thursday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $250-260 million, compared to the consensus revenue estimate of $251.9 million.Tabula Rasa HealthCare also updated its Q1 2019 guidance to EPS.

What price target have analysts set for TRHC?

10 equities research analysts have issued 12 month price targets for Tabula Rasa HealthCare's shares. Their predictions range from $58.00 to $100.00. On average, they anticipate Tabula Rasa HealthCare's share price to reach $84.2330 in the next twelve months. This suggests a possible upside of 92.2% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

What are Wall Street analysts saying about Tabula Rasa HealthCare stock?

Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock:
  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (5/23/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on TRHC shares and maintain our 12-month price target at $99. Rasa reported 1Q19 results, which appeared to be strong. We note that the company posted strong organic growth of 19%. Adjusted EBITDA was above our estimate and the company reaffirmed its 2019 guidance for revenue and adjusted EBITDA. Our EPS estimates moved lower to reflect the higher interest expense given the 1Q19 convert. While the company has executed in the short term, we suspect that investors are more concerned about the number of acquisitions the company has completed in the last two years and its integration efforts." (5/13/2019)

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Media headlines about TRHC stock have been trending somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a news impact score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Micron Technology (MU), GW Pharmaceuticals PLC- (GWPH), Align Technology (ALGN), Netflix (NFLX), QUALCOMM (QCOM), Yirendai (YRD), Workday (WDAY) and Canopy Growth (CGC).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.04%), Jennison Associates LLC (4.03%), Macquarie Group Ltd. (2.62%), Artisan Partners Limited Partnership (2.04%), Wells Fargo & Company MN (1.51%) and Citigroup Inc. (1.41%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Northern Trust Corp, Parametric Portfolio Associates LLC, Fiera Capital Corp, First Trust Advisors LP, Advisor Group Inc., Braun Stacey Associates Inc. and PNC Financial Services Group Inc.. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including Citigroup Inc., Macquarie Group Ltd., Wellington Management Group LLP, Rice Hall James & Associates LLC, Jennison Associates LLC, Osterweis Capital Management Inc., Engle Capital Management L.P. and Wells Fargo & Company MN. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $43.83.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $963.73 million and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  235 (Vote Outperform)
Underperform Votes:  210 (Vote Underperform)
Total Votes:  445
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel